UCB (BE) - Cimzia, the only PEGylated anti-TNF, approved in Europe and available in a syringe designed in partnership with OXO Good Grips

UCB announced today that the European Commission (EC) approved Cimzia®, in combination with MTX, for the treatment of moderate to severe active RA in adult patients inadequately responsive to disease-modifying antirheumatic drugs (DMARDs) including MTX.

The details can be read here.